Q4 2018 13F Holders as of 12/31/2018
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
639
-
Total shares
-
47.7M
-
Shares change
-
-2.68M
-
Total reported value, excl. options
-
$4.6B
-
Value change
-
-$271M
-
Put/Call ratio
-
1.93
-
Number of buys
-
205
-
Number of sells
-
-331
-
Price
-
$96.43
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q4 2018
674 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q4 2018.
ISHARES TR - ISHARES BIOTECH (IBB) has 639 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.7M shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (13.1M shares), MORGAN STANLEY (4.21M shares), UBS Group AG (3.23M shares), DEUTSCHE BANK AG\ (1.68M shares), GOLDMAN SACHS GROUP INC (1.52M shares), CITIGROUP INC (1.22M shares), JPMORGAN CHASE & CO (1.12M shares), WELLS FARGO & COMPANY/MN (877K shares), ROYAL BANK OF CANADA (771K shares), and NATIXIS (752K shares).
This table shows the top 639 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.